1
|
Kawecki F, Jann J, Fortin M, Auger FA, Faucheux N, Fradette J. Preclinical Evaluation of BMP-9-Treated Human Bone-like Substitutes for Alveolar Ridge Preservation following Tooth Extraction. Int J Mol Sci 2022; 23:ijms23063302. [PMID: 35328724 PMCID: PMC8952786 DOI: 10.3390/ijms23063302] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2022] [Revised: 03/07/2022] [Accepted: 03/16/2022] [Indexed: 02/06/2023] Open
Abstract
The success of dental implant treatment after tooth extraction is generally maximized by preserving the alveolar ridge using cell-free biomaterials. However, these treatments can be associated with inflammatory reactions, leading to additional bone volume loss hampering dental implant positioning. Our group developed a self-assembled bone-like substitute constituted of osteogenically induced human adipose-derived stromal/stem cells (hASCs). We hypothesized that a bone morphogenetic protein (BMP) supplementation could improve the in vitro osteogenic potential of the bone-like substitute, which would subsequently translate into enhanced alveolar bone healing after tooth extraction. ASCs displayed a better osteogenic response to BMP-9 than to BMP-2 in monolayer cell culture, as shown by higher transcript levels of the osteogenic markers RUNX2, osterix (OSX/SP7), and alkaline phosphatase after three and six days of treatment. Interestingly, BMP-9 treatment significantly increased OSX transcripts and alkaline phosphatase activity, as well as pro-angiogenic angiopoietin-1 gene expression, in engineered bone-like substitutes after 21 days of culture. Alveolar bone healing was investigated after molar extraction in nude rats. Microcomputed tomography and histological evaluations revealed similar, or even superior, global alveolar bone preservation when defects were filled with BMP-9-treated bone-like substitutes for ten weeks compared to a clinical-grade biomaterial, with adequate gingival re-epithelialization in the absence of resorption.
Collapse
Affiliation(s)
- Fabien Kawecki
- Centre de Recherche en Organogénèse Expérimentale de l’Université Laval, LOEX, Division of Regenerative Medicine, CHU de Québec Research Center-Université Laval, Quebec City, QC G1V 0A6, Canada; (F.K.); (M.F.); (F.A.A.)
- Department of Surgery, Faculty of Medicine, Université Laval, Quebec City, QC G1V 0A6, Canada
| | - Jessica Jann
- Clinical Research Center of CHU de Sherbrooke, Department of Chemical and Biotechnological Engineering, Pharmacology Institute of Sherbrooke, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada; (J.J.); (N.F.)
| | - Michel Fortin
- Centre de Recherche en Organogénèse Expérimentale de l’Université Laval, LOEX, Division of Regenerative Medicine, CHU de Québec Research Center-Université Laval, Quebec City, QC G1V 0A6, Canada; (F.K.); (M.F.); (F.A.A.)
- Faculty of Dentistry, Université Laval, Quebec City, QC G1V 0A6, Canada
- Service of Oral and Maxillofacial Surgery, CHU de Québec-Université Laval, Quebec City, QC G1V 0A6, Canada
| | - François A. Auger
- Centre de Recherche en Organogénèse Expérimentale de l’Université Laval, LOEX, Division of Regenerative Medicine, CHU de Québec Research Center-Université Laval, Quebec City, QC G1V 0A6, Canada; (F.K.); (M.F.); (F.A.A.)
- Department of Surgery, Faculty of Medicine, Université Laval, Quebec City, QC G1V 0A6, Canada
| | - Nathalie Faucheux
- Clinical Research Center of CHU de Sherbrooke, Department of Chemical and Biotechnological Engineering, Pharmacology Institute of Sherbrooke, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada; (J.J.); (N.F.)
| | - Julie Fradette
- Centre de Recherche en Organogénèse Expérimentale de l’Université Laval, LOEX, Division of Regenerative Medicine, CHU de Québec Research Center-Université Laval, Quebec City, QC G1V 0A6, Canada; (F.K.); (M.F.); (F.A.A.)
- Department of Surgery, Faculty of Medicine, Université Laval, Quebec City, QC G1V 0A6, Canada
- Correspondence:
| |
Collapse
|
2
|
Engel N, Fechner C, Voges A, Ott R, Stenzel J, Siewert S, Bergner C, Khaimov V, Liese J, Schmitz KP, Krause BJ, Frerich B. An optimized 3D-printed perfusion bioreactor for homogeneous cell seeding in bone substitute scaffolds for future chairside applications. Sci Rep 2021; 11:22228. [PMID: 34782672 PMCID: PMC8593024 DOI: 10.1038/s41598-021-01516-8] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2021] [Accepted: 10/20/2021] [Indexed: 12/03/2022] Open
Abstract
A clinical implementation of cell-based bone regeneration in combination with scaffold materials requires the development of efficient, controlled and reproducible seeding procedures and a tailor-made bioreactor design. A perfusion system for efficient, homogeneous, and rapid seeding with human adipogenic stem cells in bone substitute scaffolds was designed. Variants concerning medium inlet and outlet port geometry, i.e. cylindrical or conical diffuser, cell concentration, perfusion mode and perfusion rates were simulated in silico. Cell distribution during perfusion was monitored by dynamic [18F]FDG micro-PET/CT and validated by laser scanning microscopy with three-dimensional image reconstruction. By iterative feedback of the in silico and in vitro experiments, the homogeneity of cell distribution throughout the scaffold was optimized with adjustment of flow rates, cell density and perfusion properties. Finally, a bioreactor with a conical diffusor geometry was developed, that allows a homogeneous cell seeding (hoover coefficient: 0.24) in less than 60 min with an oscillating perfusion mode. During this short period of time, the cells initially adhere within the entire scaffold and stay viable. After two weeks, the formation of several cell layers was observed, which was associated with an osteogenic differentiation process. This newly designed bioreactor may be considered as a prototype for chairside application.
Collapse
Affiliation(s)
- Nadja Engel
- Experimental Research Laboratory, Department of Oral and Maxillofacial Surgery, Facial Plastic Surgery, Rostock University Medical Center, Schillingallee 35, 18057, Rostock, Germany
| | - Carsten Fechner
- Experimental Research Laboratory, Department of Oral and Maxillofacial Surgery, Facial Plastic Surgery, Rostock University Medical Center, Schillingallee 35, 18057, Rostock, Germany
| | - Annika Voges
- Experimental Research Laboratory, Department of Oral and Maxillofacial Surgery, Facial Plastic Surgery, Rostock University Medical Center, Schillingallee 35, 18057, Rostock, Germany
| | - Robert Ott
- Institute for Implant Technology and Biomaterials e.V, Friedrich-Barnewitz-Str. 4, 18119, Rostock, Germany
| | - Jan Stenzel
- Core Facility Multimodal Small Animal Imaging, Rostock University Medical Center, Schillingallee 69a, 18057, Rostock, Germany
| | - Stefan Siewert
- Institute for Implant Technology and Biomaterials e.V, Friedrich-Barnewitz-Str. 4, 18119, Rostock, Germany
| | - Carina Bergner
- Radiopharmacy, Department of Nuclear Medicine, Rostock University Medical Center, Gertrudenplatz 1, 18057, Rostock, Germany
| | - Valeria Khaimov
- Institute for Implant Technology and Biomaterials e.V, Friedrich-Barnewitz-Str. 4, 18119, Rostock, Germany
| | - Jan Liese
- Department of Oral and Maxillofacial Surgery, Facial Plastic Surgery, Rostock University Medical Center, Schillingallee 35, 18057, Rostock, Germany
| | - Klaus-Peter Schmitz
- Institute for Implant Technology and Biomaterials e.V, Friedrich-Barnewitz-Str. 4, 18119, Rostock, Germany
| | - Bernd Joachim Krause
- Department of Nuclear Medicine, Rostock University Medical Center, Gertrudenplatz 1, 18057, Rostock, Germany
| | - Bernhard Frerich
- Experimental Research Laboratory, Department of Oral and Maxillofacial Surgery, Facial Plastic Surgery, Rostock University Medical Center, Schillingallee 35, 18057, Rostock, Germany. .,Department of Oral and Maxillofacial Surgery, Facial Plastic Surgery, Rostock University Medical Center, Schillingallee 35, 18057, Rostock, Germany.
| |
Collapse
|
3
|
Herford AS, Lowe I, Jung P. Titanium Mesh Grafting Combined with Recombinant Human Bone Morphogenetic Protein 2 for Alveolar Reconstruction. Oral Maxillofac Surg Clin North Am 2019; 31:309-315. [PMID: 30852177 DOI: 10.1016/j.coms.2018.12.007] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
There are several methods of regenerating the maxillary and mandibular ridge to achieve orthoalveolar form with bone grafting procedures, including block onlay grafting and guided bone regeneration. Traditionally, guided bone regeneration has focused on creating a space for bone regeneration to occur. The use of a formed titanium mesh to regenerate alveolar defects was popularized in the 1980s. With the advent of other adjuncts, such as resorbable membranes, and growth factors, such as recombinant human bone morphogenetic protein 2, the predictability of the procedure has increased and a wide variety of defects can be restored using this technology.
Collapse
Affiliation(s)
- Alan S Herford
- Department of Oral and Maxillofacial Surgery, Loma Linda University School of Dentistry, 11092 Anderson Street, Loma Linda, CA 92350, USA.
| | - Isaac Lowe
- Department of Oral and Maxillofacial Surgery, Loma Linda University School of Dentistry, 11092 Anderson Street, Loma Linda, CA 92350, USA
| | - Paul Jung
- Department of Oral and Maxillofacial Surgery, Loma Linda University School of Dentistry, 11092 Anderson Street, Loma Linda, CA 92350, USA
| |
Collapse
|
4
|
Daga D, Mehrotra D, Mohammad S, Chandra S, Singh G, Mehrotra D. Tentpole technique for bone regeneration in vertically deficient alveolar ridges: A prospective study. J Oral Biol Craniofac Res 2017; 8:20-24. [PMID: 29556458 DOI: 10.1016/j.jobcr.2017.11.002] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2017] [Revised: 11/06/2017] [Accepted: 11/09/2017] [Indexed: 11/29/2022] Open
Abstract
Purpose The purpose of the study was to qualitatively and quantitatively assess bone regeneration potential of tentpole technique using beta tricalcium phosphate bone graft in vertically deficient alveolar ridges. Materials and Method This prospective study comprised of 20 patients with vertically deficient alveolar ridges, wherein thirty one implants were placed. Tenting of the soft tissue matrix was done using titanium screws and beta tricalcium phosphate synthetic bone graft was filled in the vertical defect. Clinical and radiographic assessment was done at 1, 3 and 6 months. Preoperative biochemical analysis of Osteopontin and RANKL was done and then reassesed at 3 months postoperative. Bone core collected at 6 postoperative months, while removal of screw, was analysed histologically. Results A significant gain in bone height of 2.87 ± 0.79 mm was seen at 6 months postoperative. All implants osseointegrated. Loosening of screw was seen in two patients.There was no postoperative wound dehiscence. Histologic analysis revealed new bone formation .There was no significant change in the levels of RANKL and Osteopontin at 3 months postoperative. Conclusion This is a safe and effective technique for bone regeneration in vertically deficient alveolar ridges and has minimal complications. The regenerated bone has new and viable bone content and supports implant material. More studies with long term follow up are needed to assess the stability of bone after long term loading.
Collapse
Affiliation(s)
- Dipti Daga
- Department of Oral and maxillofacial Surgery, King George's Medical University, Lucknow, India
| | - Divya Mehrotra
- Department of Oral and maxillofacial Surgery, King George's Medical University, Lucknow, India
| | - Shadab Mohammad
- Department of Oral and maxillofacial Surgery, King George's Medical University, Lucknow, India
| | - Shaleen Chandra
- Department of Oral Pathology and Microbiology, King George's Medical University, Lucknow, India
| | - Geeta Singh
- Department of Oral and maxillofacial Surgery, King George's Medical University, Lucknow, India
| | - Divya Mehrotra
- Department of Oral and maxillofacial Surgery, King George's Medical University, Lucknow, India
| |
Collapse
|